Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nuvalent, Inc. | 10%+ Owner | Class A Common Stock | 898K | $68.3M | $76.14 | Aug 2, 2021 | Direct |
Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 2.5M | $25M | $10.00 | Jun 21, 2021 | Direct |
Acrivon Therapeutics, Inc. | 10%+ Owner | Common Stock | 888K | $3.86M | $4.35 | Nov 17, 2022 | Direct |
Boundless Bio, Inc. | 10%+ Owner | Common Stock | 556K | Apr 2, 2024 | Direct | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 194K | Jul 22, 2024 | Direct | ||
Acrivon Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Nov 17, 2022 | Direct | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jul 22, 2024 | Direct | ||
Boundless Bio, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Apr 2, 2024 | Direct | ||
Boundless Bio, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Apr 2, 2024 | Direct | ||
Nuvalent, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Aug 2, 2021 | Direct | ||
Verve Therapeutics, Inc. | 10%+ Owner | Series A-2 Preferred Stock | 0 | Jun 21, 2021 | Direct | ||
Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jun 21, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARTV | Artiva Biotherapeutics, Inc. | Jul 22, 2024 | 3 | $500K | 4 | Jul 22, 2024 | 10%+ Owner |
ARTV | Artiva Biotherapeutics, Inc. | Jul 18, 2024 | 0 | $0 | 3 | Jul 18, 2024 | 10%+ Owner |
BOLD | Boundless Bio, Inc. | Apr 2, 2024 | 4 | $0 | 4 | Apr 2, 2024 | 10%+ Owner |
BOLD | Boundless Bio, Inc. | Mar 27, 2024 | 0 | $0 | 3 | Mar 27, 2024 | 10%+ Owner |
ACRV | Acrivon Therapeutics, Inc. | Nov 17, 2022 | 2 | $0 | 4 | Nov 21, 2022 | 10%+ Owner |
ACRV | Acrivon Therapeutics, Inc. | Nov 9, 2022 | 0 | $0 | 3 | Nov 9, 2022 | 10%+ Owner |
NUVL | Nuvalent, Inc. | Aug 2, 2021 | 2 | $0 | 4 | Aug 3, 2021 | 10%+ Owner |
NUVL | Nuvalent, Inc. | Jul 28, 2021 | 0 | $0 | 3 | Jul 28, 2021 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 21, 2021 | 4 | $0 | 4 | Jun 22, 2021 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | 10%+ Owner |